GSK finds buyer for European OTC brands in Omega
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has found a buyer for its non-core OTC brands in Europe. Omega Pharma of Belgium is acquiring the portfolio for €470 million (£391 million) in cash.